Execution delays in battery and semiconductor verticals
Pilot plant capex delayed due to equipment arrival; second phase of battery chemicals capex spills into FY27. Any further delays could impact revenue ramp-up.
ACUTAAS / Q3-FY26 / risks
Keep the risk register visible.
Acutaas Chemicals · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Product concentration risk in CDMO
Top CDMO product (oncology) drives a significant portion of growth. Analyst raised concern about concentration; management acknowledged but did not provide specific derisking timeline.
Chinese competition in intermediates
Chinese competitors remain a threat across segments. Management claims strong chemistry capabilities and market leadership in key products, but competition could pressure pricing.
Working capital days elevated
Net working capital days at 111, with debtor days at 100. Management considers 110 days standard, but any deterioration could strain cash flows.